Cleveland Clinic

Think You May Be Stressed? Here are 3 Physical Signs of Chronic Stress from The Chicago School President, Dr. Michele Nealon, Psy.D.

Retrieved on: 
Tuesday, February 13, 2024

Finding ways to manage stress levels is critical to our mental and physiological health and wellness, according to Dr. Michele Nealon, a clinical psychologist, and President of the Chicago School.

Key Points: 
  • Finding ways to manage stress levels is critical to our mental and physiological health and wellness, according to Dr. Michele Nealon, a clinical psychologist, and President of the Chicago School.
  • Dr. Nealon has said, “Stress can cause major mental health challenges over time.
  • Specifically, chronic stress can lead to anxiety and depression and can also cause chronic health conditions such as high blood pressure, increased risk of stroke, and substance abuse challenges.
  • Rest assured that you are not alone in your battle with chronic stress, no matter how isolating it may feel.

New Study Identifies Increased Fracture Risk for Older Pickleball Players

Retrieved on: 
Monday, February 12, 2024

The Sports and Fitness Industry Association identified an 11.5% average annual growth rate of pickleball players over the past five years, with approximately 1.4 million "core" players (those who play more than eight times per year) in 2020.

Key Points: 
  • The Sports and Fitness Industry Association identified an 11.5% average annual growth rate of pickleball players over the past five years, with approximately 1.4 million "core" players (those who play more than eight times per year) in 2020.
  • A highlight of findings from the study include:
    Throughout the study, there was a 90-fold increase in fractures, with a noticeable surge from 2020 onward where fractures doubled.
  • Despite the female predominance in fractures, men were 2.3 times more likely to be admitted for a fracture.
  • "It's important to understand your risk profile of injury and to speak with your physician to see how you can lower your risk.

Rita Case Wins Prestigious TIME Dealer of the Year Award

Retrieved on: 
Thursday, February 8, 2024

Rita Case, president and CEO of Rick Case Automotive Group, the nation’s largest female owned and operated automotive dealer group in America, received the 55th Annual TIME Dealer of the Year Award, one of the automotive industry’s most prestigious and highest honors for a dealer.

Key Points: 
  • Rita Case, president and CEO of Rick Case Automotive Group, the nation’s largest female owned and operated automotive dealer group in America, received the 55th Annual TIME Dealer of the Year Award, one of the automotive industry’s most prestigious and highest honors for a dealer.
  • Rita is only the fifth woman to be named TIME Dealer of the Year.
  • TIME Dealer of the Year is the highest honor and most prestigious recognition an auto dealer can receive from the auto industry, and I am humbled and grateful for this award,” Rita said, as she received the award during the 107th Annual NADA Show in Las Vegas.
  • In 2023, the Community Foundation of Broward recognized Rita as a Community Builder and celebrated the establishment of the Rita & Rick Case Family Fund during a special ceremony.

Cleveland Clinic teams up with American Greetings to offer Valentine's Day Creatacard™ Virtual Greeting Cards

Retrieved on: 
Thursday, February 8, 2024

CLEVELAND, Feb. 8, 2024 /PRNewswire/ -- According to the Centers for Disease Control and Prevention (CDC), heart disease is the number one killer of women and men in the United States, causing one in every five deaths. For the second year running, in celebration of Valentine's Day and Heart Month, Cleveland Clinic and American Greetings are proud to collaborate in ways that may improve cardiovascular health everywhere by offering a selection of beautiful Creatacard™ virtual greetings cards for those who donate to support Cleveland Clinic's cardiovascular research.

Key Points: 
  • For the second year running, in celebration of Valentine's Day and Heart Month, Cleveland Clinic and American Greetings are proud to collaborate in ways that may improve cardiovascular health everywhere by offering a selection of beautiful Creatacard™ virtual greetings cards for those who donate to support Cleveland Clinic's cardiovascular research.
  • With each $20 donation, individuals will have the opportunity to send personalized Valentine's Day Creatacards, designed by artists at American Greetings, to all the loved ones on their list.
  • Creatacard™ is an easy-to-create custom virtual greeting card that replicates the most-loved features of paper cards such as adding a personal message, signing your name, and including photos.
  • Since 1995, Cleveland Clinic has ranked number one in cardiac care, according to U.S. News & World Report.

BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases

Retrieved on: 
Tuesday, February 6, 2024

Available by subscription, PURE EP™’s NFT algorithm monitors changes in the local unipolar electrogram, empowering electrophysiologists with tissue-specific feedback and color-coded characterization in real time.

Key Points: 
  • Available by subscription, PURE EP™’s NFT algorithm monitors changes in the local unipolar electrogram, empowering electrophysiologists with tissue-specific feedback and color-coded characterization in real time.
  • Since its launch in Q4 2023, the software has been leveraged at some of the largest and leading medical centers and health systems in the country.
  • Researchers from Cleveland Clinic presented topline clinical findings on the value of NFT at the Heart Rhythm 2023 convention held last May.
  • To learn more about PURE EP™’s growing suite of proprietary software-based features, click here .

EQS-News: Immunic to Participate in Investor and Scientific Conferences in February

Retrieved on: 
Monday, February 5, 2024

NEW YORK, February 1, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor and scientific conferences in February:

Key Points: 
  • NEW YORK, February 1, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor and scientific conferences in February:
    February 8: BioCapital Europe 2024.
  • Daniel Vitt, Ph.D., Chief Executive Officer and President of Immunic, and Jessica Breu, Vice President Investor Relations and Communications, will attend this conference in Amsterdam and host one-on-one investor meetings.
  • The poster presentations will be accessible on the "Events and Presentations" section of Immunic's website at: https://ir.imux.com/events-and-presentations .
  • Poster Title: Impact of Vidofludimus Calcium on Serum Neurofilament in Progressive MS: Data from the CALLIPER Interim Analysis
    Presenting Author: Robert J.

BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy

Retrieved on: 
Tuesday, January 30, 2024

Westport, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) --  BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced a workforce reduction, intended to reduce annual cash burn by 50%.  The Company is reducing its internal workforce, which is expected to be completed by January 31. The Company is also shifting its business model and seeks to partner with organizations for sales distribution and clinical support of its PURE EP™ Platform.

Key Points: 
  • The Company is reducing its internal workforce, which is expected to be completed by January 31.
  • The Company is also shifting its business model and seeks to partner with organizations for sales distribution and clinical support of its PURE EP™ Platform.
  • "BioSig is at an important juncture, and we are taking steps to streamline our corporate structure.
  • Their hard work and dedication were integral to bringing the PURE EP™ Platform to where it is today," said Ken Londoner, Chairman and CEO of BioSig.

Hundreds of Physicians Rebuke Duke University for Killing Animals to Train Medical Students

Retrieved on: 
Friday, February 2, 2024

In a letter sent today to Duke, 552 physicians are urging the university to halt the controversial practice of using and killing animals to train medical students.

Key Points: 
  • In a letter sent today to Duke, 552 physicians are urging the university to halt the controversial practice of using and killing animals to train medical students.
  • The letter, spearheaded by the national medical ethics group Physicians Committee for Responsible Medicine, points out that no other medical school in the United States or Canada is known to kill animals to train students, and none has done so since 2016.
  • Duke only reinstated the practice, in which invasive surgical procedures are performed on pigs, recently and has separately come under fire by medical training experts.
  • “Duke is better than this,” said John Pippin, MD, FACC, director of academic affairs for the Physicians Committee.

Lazard Appoints Dan Schulman and Stephen R. Howe Jr. to Its Board of Directors

Retrieved on: 
Tuesday, January 30, 2024

“We are thrilled that Dan and Steve are joining our Board of Directors,” said Peter R. Orszag, Chief Executive Officer and Director, Lazard.

Key Points: 
  • “We are thrilled that Dan and Steve are joining our Board of Directors,” said Peter R. Orszag, Chief Executive Officer and Director, Lazard.
  • Stephen R. Howe Jr. is a widely respected executive, board member, and financial services, audit, and corporate governance expert.
  • “Lazard serves an important role in the financial services landscape, and it is an honor to serve as a member of its Board of Directors.
  • I look forward to working with Peter and fellow Directors, and leveraging my experience on behalf of the firm,” said Mr. Howe.

Immunic to Participate in Investor and Scientific Conferences in February

Retrieved on: 
Thursday, February 1, 2024

NEW YORK, Feb. 1, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor and scientific conferences in February:

Key Points: 
  • NEW YORK, Feb. 1, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor and scientific conferences in February:
    February 8: BioCapital Europe 2024.
  • Daniel Vitt, Ph.D., Chief Executive Officer and President of Immunic, and Jessica Breu, Vice President Investor Relations and Communications, will attend this conference in Amsterdam and host one-on-one investor meetings.
  • To schedule a meeting, please use the BioCapital conference portal or contact Jessica Breu at: [email protected] .
  • Poster Title: Impact of Vidofludimus Calcium on Serum Neurofilament in Progressive MS: Data from the CALLIPER Interim Analysis
    Presenting Author: Robert J.